Literature DB >> 1665200

Alterations in cardiac function and subcellular membrane activities after hypervitaminosis D3.

S Takeo1, R Tanonaka, K Tanonaka, K Miyake, H Hisayama, N Ueda, K Kawakami, H Tsumura, S Katsushika, Y Taniguchi.   

Abstract

The present study was designed to induce massive accumulation of calcium in the myocardium and to evaluate the effect of calcium overload on myocardial contractile function and biochemical activity of cardiac subcellular membranes. Rats were treated with an oral administration of 500,000 units/kg of vitamin D3 for 3 consecutive days, and their hearts were sampled on the 5th day for biochemical analysis. On the 4th and 5th days, heart rate, mean aortic pressure, left ventricular systolic pressure and left ventricular dP/dt were significantly lowered in vitamin D3-treated rats, demonstrating the existence of appreciable myocardial contractile dysfunction. Marked increases in the myocardial calcium (67-fold increase) and mitochondrial calcium contents (24-fold increase) were observed by hypervitaminosis D3. Mitochondrial oxidative phosphorylation and ATPase activity were significantly reduced by this treatment. A decline in sarcolemmal Na+, K(+)-ATPase activity was also observed, while relatively minor or insignificant changes in calcium uptake and ATPase activities of sarcoplasmic reticulum were detectable. Electron microscopic examination revealed calcium deposits in the mitochondria after vitamin D3 treatment. The results suggest that hypervitaminosis D3 produces massive accumulation of calcium in the myocardium, particularly in the cardiac mitochondrial membrane, which may induce an impairment in the mitochondrial function and eventually may lead to a failure in the cardiac contractile function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665200     DOI: 10.1007/bf00225520

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  A study of Ca 2+ metabolism in kidney mitochondria during acute uranium intoxication.

Authors:  E Carafoli; R Tiozzo; I Pasquali-Ronchetti; R Laschi
Journal:  Lab Invest       Date:  1971-12       Impact factor: 5.662

2.  Biochemical basis of heart function. IV. Energy metabolism and calcium transport in hearts of vitamin E deficient rats.

Authors:  M Fedelesova; P V Sulakhe; J C Yates; N S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  1971-10       Impact factor: 2.273

3.  Depressed Na-K-ATPase activity in the failing rabbit heart.

Authors:  Y Yazaki; J Fujii
Journal:  Jpn Heart J       Date:  1972-01

4.  Intracellular calcium and myocardial contractility. 3. Reduced calcium uptake and ATPase of the sarcoplasmic reticular fraction prepared from chronically failing calf hearts.

Authors:  J Suko; J H Vogel; C A Chidsey
Journal:  Circ Res       Date:  1970-08       Impact factor: 17.367

5.  Myocardial cation contents during induction of calcium paradox.

Authors:  L E Alto; N S Dhalla
Journal:  Am J Physiol       Date:  1979-12

6.  Thyroxine-induced redistribution of isoenzymes of rabbit ventricular myosin.

Authors:  A F Martin; E D Pagani; R J Solaro
Journal:  Circ Res       Date:  1982-01       Impact factor: 17.367

7.  The biochemistry of uncontrolled calcium entry.

Authors:  W G Nayler; J S Elz; S E Perry; M J Daly
Journal:  Eur Heart J       Date:  1983-12       Impact factor: 29.983

8.  Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.

Authors:  G A Beller; J Conroy; T W Smith
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

9.  Comparison of heart sarcolemmal enzyme activities in normal and cardiomyopathic (UM-X7.1) hamsters.

Authors:  N S Dhalla; J N Singh; E Bajusz; G Jasmin
Journal:  Clin Sci Mol Med       Date:  1976-09

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  1 in total

1.  Protective effect of propranolol on mitochondrial function in the ischaemic heart.

Authors:  Takeshi Iwai; Kouichi Tanonaka; Sayaka Kasahara; Rie Inoue; Satoshi Takeo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.